Interferon Gamma ELISPOT Testing as a Risk‐Stratifying Biomarker for Kidney Transplant Injury: Results From the CTOT‐01 Multicenter Study

Publisher: John Wiley & Sons Inc

E-ISSN: 1600-6143|15|12|3166-3173

ISSN: 1600-6135

Source: AMERICAN JOURNAL OF TRANSPLANTATION, Vol.15, Iss.12, 2015-12, pp. : 3166-3173

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content